AAAAAA
Results: 1-25/105
Authors:
GAYTHER SA
PONDER BAJ
Citation: Sa. Gayther et Baj. Ponder, CLUES TO THE FUNCTION OF THE TUMOR SUSCEPTIBILITY GENE BRCA2, Disease markers, 14(1), 1998, pp. 1-8
Authors:
SJOROOS M
ILONEN J
REIJONEN H
LOVGREN T
Citation: M. Sjoroos et al., TIME-RESOLVED FLUOROMETRY BASED SANDWICH HYBRIDIZATION ASSAY FOR HLA-DQA1 TYPING, Disease markers, 14(1), 1998, pp. 9-19
Citation: ABSTRACTS OF THE 7TH INTERNATIONAL WORKSHOP ON AT, NOVEMBER, 1997, CLERMONT-FERRAND, FRANCE, Disease markers, 14(1), 1998, pp. 21-89
Authors:
KILPATRICK DC
Citation: Dc. Kilpatrick, HLA-B27 DETERMINATION BY PCR, DISEASE MARKERS (VOL 12, PG 247, 1996), Disease markers, 13(4), 1998, pp. 1-1
Authors:
STEEL M
Citation: M. Steel, UNTITLED, Disease markers, 13(4), 1998, pp. 207-207
Authors:
GUDNASON V
ZHOU T
THORMAR K
BAEHRING S
COOPER J
MILLER G
HUMPHRIES SE
SCHUSTER H
Citation: V. Gudnason et al., DETECTION OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE PVUII INTRON-15 POLYMORPHISM USING THE POLYMERASE-CHAIN-REACTION - ASSOCIATION WITH PLASMA-LIPID TRAITS IN HEALTHY-MEN AND WOMEN, Disease markers, 13(4), 1998, pp. 209-220
Authors:
CASCINO I
BALLERINI C
AUDINO S
ROMBOLA G
MASSACESI L
COLOMBO G
SMERALDI RS
DALFONSO S
RICHIARDI PM
TOSI R
RUBERTI G
Citation: I. Cascino et al., FAS GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, MULTIPLE-SCLEROSIS AND HIV-INFECTION, Disease markers, 13(4), 1998, pp. 221-225
Authors:
BOLLA MK
MILLER GJ
YELLON DM
EVANS A
LUC G
CAMBOU JP
ARVEILER D
CAMBIEN F
LATCHMAN DS
HUMPHRIES SE
DAY INM
Citation: Mk. Bolla et al., ANALYSIS OF THE ASSOCIATION OF A HEAT-SHOCK PROTEIN70-1 GENE PROMOTERPOLYMORPHISM WITH MYOCARDIAL-INFARCTION AND CORONARY RISK TRAITS, Disease markers, 13(4), 1998, pp. 227-235
Authors:
JONES SB
FRANKLIN J
Citation: Sb. Jones et J. Franklin, A STRATEGY AND DEMONSTRATION FOR INTEGRATED BIOTECHNOLOGY INFORMATION, Disease markers, 13(4), 1998, pp. 237-243
Authors:
MITCHELL JL
DOYLE CM
LAND MV
DEVINE PL
Citation: Jl. Mitchell et al., COMPARISON OF COMMERCIAL ELISA FOR DETECTION OF ANTIBODIES TO THE VIRAL CAPSID ANTIGEN (VCA) OF EPSTEIN-BARR-VIRUS (EBV), Disease markers, 13(4), 1998, pp. 245-249
Authors:
RASMUSSEN HB
KELLY MA
FRANCIS DA
CLAUSEN J
Citation: Hb. Rasmussen et al., HAPLOTYPES OF THE ENDOGENOUS RETROVIRUS HRES-1 IN MULTIPLE-SCLEROSIS PATIENTS AND HEALTHY CONTROL SUBJECTS OF SHANGHAI CHINESE ORIGIN, Disease markers, 13(4), 1998, pp. 251-255
Authors:
SANDFORD AJ
CHAGANI T
WEIR TD
PARE PD
Citation: Aj. Sandford et al., ALPHA(1)-ANTICHYMOTRYPSIN MUTATIONS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, Disease markers, 13(4), 1998, pp. 257-260
Authors:
PATERSON JWE
Citation: Jwe. Paterson, BRCA1 - A REVIEW OF STRUCTURE AND PUTATIVE FUNCTIONS, Disease markers, 13(4), 1998, pp. 261-274
Citation: FIRST INTERNATIONAL WORKSHOP ON THE FUNCTION OF BRCA1 AND BRCA2, SEPTEMBER 11-12, 1997, THE MOLLER-CENTRE, CHURCHILL-COLLEGE, CAMBRIDGE, UK- ABSTRACTS, Disease markers, 13(4), 1998, pp. 275-287
Authors:
WEISS N
GUDNASSON V
OSTWALD P
HUMPHRIES S
SCHUSTER H
KELLER C
Citation: N. Weiss et al., THE USEFULNESS OF 3 BIALLELIC RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS VERSUS A POLYMORPHIC DINUCLEOTIDE TANDEM REPEAT POLYMORPHISM AT THELOW-DENSITY-LIPOPROTEIN RECEPTOR GENE LOCUS FOR DIAGNOSIS OF FAMILIALHYPERCHOLESTEROLEMIA, Disease markers, 13(3), 1997, pp. 141-151
Authors:
KALA P
KOPTIDES M
DIANGELO S
HOOVER RR
LIN ZW
VELETZA V
KOURETAS D
FLOROS J
Citation: P. Kala et al., CHARACTERIZATION OF MARKERS FLANKING THE HUMAN SP-B LOCUS, Disease markers, 13(3), 1997, pp. 153-167
Authors:
LUCARINI N
BOTTINI N
ANTONACCI E
BORGIANI P
FAGGIONI G
GLORIABOTTINI F
Citation: N. Lucarini et al., DIABETIC COMPLICATIONS AND THE GENETICS OF SIGNAL-TRANSDUCTION - A STUDY OF RETINOPATHY IN NIDDM, Disease markers, 13(3), 1997, pp. 169-176
Authors:
MABROUK GM
Citation: Gm. Mabrouk, PREVALENCE OF HEPATITIS-C INFECTION AND SCHISTOSOMIASIS IN EGYPTIAN PATIENTS WITH HEPATOCELLULAR-CARCINOMA, Disease markers, 13(3), 1997, pp. 177-182
Authors:
FAHIM FA
ESMAT AY
MADY EA
AMIN MA
Citation: Fa. Fahim et al., SERUM LDH AND ALP ISOZYME ACTIVITIES IN MICE BEARING SOLID EHRLICH CARCINOMA AND OR TREATED WITH THE MAXIMUM TOLERATED DOSE (MTD) OF ALOIN/, Disease markers, 13(3), 1997, pp. 183-193
Authors:
BANSAL AS
BRUCE J
DEVINE PL
SCELLS B
ZIMMERMANN PV
Citation: As. Bansal et al., SERUM CYTOKINES AND TUMOR-MARKERS IN PATIENTS WITH NONSMALL CELL-CARCINOMA OF THE LUNG, Disease markers, 13(3), 1997, pp. 195-199
Authors:
DOYLE A
PACKER P
Citation: A. Doyle et P. Packer, SECURING BIOTECHNOLOGICAL RESOURCES - THE PLACE OF THE RESOURCE CENTER, Disease markers, 13(2), 1997, pp. 71-76
Authors:
WULFF K
EBENER U
WEHNERT CS
WARD PA
REUNER U
HIEBSCH W
HERRMANN FH
WEHNERT M
Citation: K. Wulff et al., DIRECT MOLECULAR-GENETIC DIAGNOSIS AND HETEROZYGOTE IDENTIFICATION INX-LINKED EMERY-DREIFUSS MUSCULAR-DYSTROPHY BY HETERODUPLEX ANALYSIS, Disease markers, 13(2), 1997, pp. 77-86
Authors:
SAMILCHUK E
DSOUZA B
VOEVODIN A
CHUCHALIN A
ALAWADI S
Citation: E. Samilchuk et al., TAQI-POLYMORPHISM IN THE 3' FLANKING REGION OF THE PI-GENE AMONG KUWAITI-ARABS AND RUSSIANS, Disease markers, 13(2), 1997, pp. 87-92
Authors:
GRENNAN DM
PARFITT A
MANOLIOS N
HUANG Q
HYLAND V
DUNCKLEY H
DORAN T
GATENBY P
BADCOCK C
Citation: Dm. Grennan et al., FAMILY AND TWIN STUDIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Disease markers, 13(2), 1997, pp. 93-98
Authors:
ESSAWI M
GAD YZ
ELROUBY O
TEMTAMY SA
SABOUR YA
ELAWADY MK
Citation: M. Essawi et al., MOLECULAR ANALYSIS OF ANDROGEN RESISTANCE SYNDROMES IN EGYPTIAN PATIENTS, Disease markers, 13(2), 1997, pp. 99-105